Page 409 - Binder2

This chapter argues that the real innovation isn’t the
duckweed, the chloroplast, or the freeze-dried capsule.

It’s the chance to reimagine the entire system.

A system where:

• Durability means not just a long-lasting therapy,
but a long-lasting supply chain.
• Access isn’t a goal—it’s a requirement.
• Ownership doesn’t rest in boardrooms, but in
communities.

Because a drug that is affordable, ethical, and locally
grown isn’t just good medicine.

It’s justice in molecular form.

7.5 – The AI Engine Behind the Revolution

At first glance, edible biologics feel like a return to
simplicity.

Grow a plant. Harvest its leaves. Freeze-dry the tissue.
Deliver the medicine in a capsule, a powder, or even a
salad. No vials. No syringes. No cold chain. It seems
deceptively low-tech.

But that simplicity is an illusion—one made possible only
by one of the most complex and transformative forces in
modern medicine: artificial intelligence.

Edible biologics are not a step backward to rustic
herbalism. They’re a step forward to something profoundly

407